BCPC

Balchem Corp.

Halal Rating :
Comfortable
Last Price $159
Market Cap $5.2b
1D Change

0.0 %

1 Year Change

13.98 %

Next Earnings Date

Yet to be announced

Company Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates through three segments: Human Nutrition, Animal Nutrition & Health, and Specialty Products. The company sells its products through sales force, independent distributors, and sales agents.

Revenue Sources

Pass

Based on review of Balchem's business segments and revenue sources, the company primarily derives its income from halal sources including nutritional ingredients, food additives, and industrial products. None of their major revenue streams come from prohibited sources such as alcohol, pork, gambling, or other haram activities.

Reliance on Interest

Pass
Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $239.94m $191.95m - - 0.00% 0.00%
June 30, 2024 $234.08m $188.28m - - 0.00% 0.00%
March 31, 2024 $239.66m $203.38m - $5.4m 0.00% 2.65%
Dec. 31, 2023 $228.7m $190.36m - - 0.00% 0.00%

Analysis of the company's financial statements over the past four quarters shows minimal interest expense, with only one quarter showing any interest expense at all. The interest expense ratio in the quarter where it appeared was well below concerning levels. The company's operations are not materially dependent on interest income or expense.

Operational Ethics

Pass

After reviewing available public information, SEC filings, and company documentation, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company's operations are primarily focused in North America and Europe, with no significant presence or partnerships in concerning regions.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion

Recent News & Updates